drugset / Trial / NCT00565409

Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

NCT00565409

Phase 4 Completed 834 enrolled Pfizer
RandomizedParallel-groupTriple-blindTreatment

Summary

To compare the efficacy of the combination of etanercept 50 mg once weekly plus methotrexate with that of methotrexate monotherapy in the treatment of rheumatoid arthritis over 88 weeks.

Timeline

Start
2008-03
Primary completion
2011-05
Completion
2011-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etanercept Protein / enzyme biologic 25 mg Subcutaneous
Comparator Etanercept Protein / enzyme biologic 50 mg Subcutaneous
Comparator Methotrexate Small molecule 15 mg Oral
Comparator Methotrexate Small molecule 25 mg Oral

Indications